Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin

The prognosis of locally advanced gastric cancer is poor even if radical gastrectomy with D2 lymphadenectomy is followed by adjuvant chemotherapy. Hence, neoadjuvant chemotherapy is performed to try to improve the prognosis, as it can significantly downstage the tumor and safely improve the R0 resec...

Full description

Bibliographic Details
Main Authors: Masato Kondo, Shogo Nishino, Daisuke Yamashita, Satoshi Kaihara
Format: Article
Language:English
Published: Karger Publishers 2020-06-01
Series:Case Reports in Oncology
Subjects:
s-1
Online Access:https://www.karger.com/Article/FullText/507983
id doaj-79ada4a3b907443fa76d91666f7f3c57
record_format Article
spelling doaj-79ada4a3b907443fa76d91666f7f3c572020-11-25T03:59:49ZengKarger PublishersCase Reports in Oncology1662-65752020-06-0113271672010.1159/000507983507983Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and OxaliplatinMasato KondoShogo NishinoDaisuke YamashitaSatoshi KaiharaThe prognosis of locally advanced gastric cancer is poor even if radical gastrectomy with D2 lymphadenectomy is followed by adjuvant chemotherapy. Hence, neoadjuvant chemotherapy is performed to try to improve the prognosis, as it can significantly downstage the tumor and safely improve the R0 resection rate of patients. Herein, we report a case of locally advanced gastric cancer with pancreatic invasion and gastric outlet obstruction that showed a pathological complete response after neoadjuvant chemotherapy with S-1 and oxaliplatin (SOX). A 74-year-old man presented to our hospital with abdominal pain and pyloric stenosis. CT images revealed a cStage IVb, cT4b tumor in the pancreas, cN1, cM0. Therefore, we performed laparoscopic gastrojejunostomy, and the patient’s oral intake improved after surgery; we then administered neoadjuvant chemotherapy with SOX on postoperative day 18, without any surgical complications. After 3 courses of neoadjuvant chemotherapy, the patient underwent radical distal gastrectomy, thereby avoiding pancreatoduodenectomy. Histopathological examination of the resected sample revealed no residual cancer cells, indicating a pathological complete response. No recurrence has occurred for 1 year after surgery. Thus, neoadjuvant chemotherapy with SOX can help in tumor downstaging and may be a multipotent option for the treatment of locally advanced gastric cancer, such as cases with the invasion of other organs; this treatment can result in improved curability and avoid overinvasive surgery.https://www.karger.com/Article/FullText/507983neoadjuvant chemotherapys-1oxaliplatinpathological complete responsegastric cancer
collection DOAJ
language English
format Article
sources DOAJ
author Masato Kondo
Shogo Nishino
Daisuke Yamashita
Satoshi Kaihara
spellingShingle Masato Kondo
Shogo Nishino
Daisuke Yamashita
Satoshi Kaihara
Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
Case Reports in Oncology
neoadjuvant chemotherapy
s-1
oxaliplatin
pathological complete response
gastric cancer
author_facet Masato Kondo
Shogo Nishino
Daisuke Yamashita
Satoshi Kaihara
author_sort Masato Kondo
title Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
title_short Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
title_full Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
title_fullStr Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
title_full_unstemmed Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
title_sort complete response of locally advanced gastric cancer with pancreatic invasion and gastric outlet obstruction after neoadjuvant chemotherapy with s-1 and oxaliplatin
publisher Karger Publishers
series Case Reports in Oncology
issn 1662-6575
publishDate 2020-06-01
description The prognosis of locally advanced gastric cancer is poor even if radical gastrectomy with D2 lymphadenectomy is followed by adjuvant chemotherapy. Hence, neoadjuvant chemotherapy is performed to try to improve the prognosis, as it can significantly downstage the tumor and safely improve the R0 resection rate of patients. Herein, we report a case of locally advanced gastric cancer with pancreatic invasion and gastric outlet obstruction that showed a pathological complete response after neoadjuvant chemotherapy with S-1 and oxaliplatin (SOX). A 74-year-old man presented to our hospital with abdominal pain and pyloric stenosis. CT images revealed a cStage IVb, cT4b tumor in the pancreas, cN1, cM0. Therefore, we performed laparoscopic gastrojejunostomy, and the patient’s oral intake improved after surgery; we then administered neoadjuvant chemotherapy with SOX on postoperative day 18, without any surgical complications. After 3 courses of neoadjuvant chemotherapy, the patient underwent radical distal gastrectomy, thereby avoiding pancreatoduodenectomy. Histopathological examination of the resected sample revealed no residual cancer cells, indicating a pathological complete response. No recurrence has occurred for 1 year after surgery. Thus, neoadjuvant chemotherapy with SOX can help in tumor downstaging and may be a multipotent option for the treatment of locally advanced gastric cancer, such as cases with the invasion of other organs; this treatment can result in improved curability and avoid overinvasive surgery.
topic neoadjuvant chemotherapy
s-1
oxaliplatin
pathological complete response
gastric cancer
url https://www.karger.com/Article/FullText/507983
work_keys_str_mv AT masatokondo completeresponseoflocallyadvancedgastriccancerwithpancreaticinvasionandgastricoutletobstructionafterneoadjuvantchemotherapywiths1andoxaliplatin
AT shogonishino completeresponseoflocallyadvancedgastriccancerwithpancreaticinvasionandgastricoutletobstructionafterneoadjuvantchemotherapywiths1andoxaliplatin
AT daisukeyamashita completeresponseoflocallyadvancedgastriccancerwithpancreaticinvasionandgastricoutletobstructionafterneoadjuvantchemotherapywiths1andoxaliplatin
AT satoshikaihara completeresponseoflocallyadvancedgastriccancerwithpancreaticinvasionandgastricoutletobstructionafterneoadjuvantchemotherapywiths1andoxaliplatin
_version_ 1724452770486943744